trial
as of 2026-07-01Remediation of Visual Perceptual Impairments in People With Schizophrenia
NCTId NCT03314129
at a glance
— · Completed
Enrollment 79 (actual)
Sponsored by University of Rochester
Primary completion 2025-03-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
79 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2018-06-01
Primary completion
2025-03-31
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
University of RochesterLead Sponsor
New York UniversityCollaborator
Weill Medical College of Cornell UniversityCollaborator
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
Steven M Silverstein, Ph.D.Principal Investigator
Sites
2 total
Rochester, United StatesWhite Plains, United States
Facts & assertions
4 sourced
Enrollment
79
Phase
NA
Primary Completion Date
2025-03-31
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator